SCHEMBL7985707

SCHEMBL7985707

COc1ccc(Cn2cnc3[nH]c(-c4ccccc4)nc(=O)c32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 2/20 0.47
CYP11B1 P15538 1/20 0.47
PARN O95453 1/20 0.46
CNOT7 Q9UIV1 1/20 0.46
CXCR2 P25025 1/20 0.45
NPBWR1 P48145 1/20 0.44
HPGD P15428 4/20 0.43
P2RX7 Q99572 3/20 0.43
GAA P10253 2/20 0.43
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43
NPC1 O15118 1/20 0.43
TNKS O95271 1/20 0.43
GUSB P08236 1/20 0.43
PARP1 P09874 1/20 0.43
CASP3 P42574 1/20 0.43
RAB9A P51151 1/20 0.43
SENP7 Q9BQF6 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985228 0.96 CXCR2 (0.50) CYP11B2CYP11B1PARNCNOT7CXCR2
SCHEMBL7975271 0.89 CNOT7 (0.56) PARNCNOT7CXCR2HPGDALDH1A1
SCHEMBL7974021 0.89 TP53 (0.51) PARNCNOT7P2RX7GAAALDH1A1
SCHEMBL7974586 0.89 GAA (0.52) PARNCNOT7P2RX7GAAMAPT
SCHEMBL7985350 0.88 GAA (0.48) PARNCNOT7HPGDP2RX7GAA
SCHEMBL7984720 0.88 CNOT7 (0.48) CYP11B2CYP11B1PARNCNOT7HPGD
SCHEMBL7991406 0.86 CNOT7 (0.49) CYP11B2CYP11B1PARNCNOT7CXCR2
SCHEMBL7974480 0.86 GUSB (0.50) PARNCNOT7HPGDP2RX7KDM4E
SCHEMBL7986522 0.85 CNOT7 (0.48) CYP11B2CYP11B1PARNCNOT7HPGD
SCHEMBL7974492 0.85 ABCC8 (0.47) PARNCNOT7HPGDP2RX7GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed